Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) Yale University |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00000192 |
The purpose of this study is to evaluate the effects of lamotrigine on naloxone-precipitated opiate withdrawal.
Condition | Intervention | Phase |
---|---|---|
Opioid-Related Disorders |
Drug: Lamotrigine |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Double-Blind, Placebo Control |
Official Title: | Neurobiology of Opioid Dependence: 1 |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Please contact site for information.
United States, Connecticut | |
VA Connecticut Healthcare System | |
New Haven, Connecticut, United States, 06519 |
Principal Investigator: | Marc I Rosen, M.D. | VA Connecticut Healthcare System |
Study ID Numbers: | NIDA-00191-1, K20-00191-1 |
Study First Received: | September 20, 1999 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00000192 |
Health Authority: | United States: Federal Government |
Calcium, Dietary Mental Disorders Lamotrigine |
Substance-Related Disorders Disorders of Environmental Origin Opioid-Related Disorders |
Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Therapeutic Uses Calcium Channel Blockers |
Cardiovascular Agents Central Nervous System Agents Anticonvulsants Pharmacologic Actions |